Table 3.
Comparison of infection between the two groups before and after propensity score matching.
| Variables | Before matching | P value | After matching | P value | ||
|---|---|---|---|---|---|---|
| Ertapenem | Non-ertapenem | Ertapenem | Non-ertapenem | |||
| (n=78) (%) | (n=197) (%) | (n= 65) (%) | (n=65 ) (%) | |||
| Infectious complications | 14 (17.9) | 64 (32.5) | 0.016∗ | 8 (12.3) | 20 (30.8) | 0.010∗ |
| Remote site infections | 9 (11.5) | 30 (15.2) | 0.429 | 5 (7.7) | 7 (10.8) | 0.545 |
| Respiratory infection | 7 (9.0) | 20 (10.2) | 0.767 | 3 (4.6) | 5 (7.7) | 0.465 |
| Urinary tract infection | 1 (1.3) | 6 (3.0) | 0.403 | 1 (1.5) | 2 (3.1) | 0.559 |
| Catheter infection | 3 (3.8) | 9 (4.6) | 0.792 | 1 (1.5) | 2 (3.1) | 0.559 |
| Surgical site infections | 7 (9.0) | 44 (22.3) | 0.010∗ | 5 (7.7) | 14 (21.5) | 0.025∗ |
| Incision SSI | 5 (6.4) | 25 (12.7) | 0.132 | 4 (6.2) | 8 (12.3) | 0.226 |
| Organ/space SSI | 4 (5.1) | 25 (12.7) | 0.066 | 2 (3.1) | 9 (13.8) | 0.027∗ |